[Ansprechen follikulotroper Mycosis fungoides auf Capecitabin]

Angela Estenaga; Luisa Sanchez-Lorenzo; Javier Antoñanzas-Pérez; Ana Morelló-Vicente; Inés Oteiza-Rius; Carolina Arean Cuns; Jillian Wells; Francisco Javier García-Martínez

doi:10.1111/ddg.15066_g

[Ansprechen follikulotroper Mycosis fungoides auf Capecitabin]

J Dtsch Dermatol Ges. 2023 Jul;21(7):792-794. doi: 10.1111/ddg.15066_g.

[Article in German]

Authors

Angela Estenaga¹, Luisa Sanchez-Lorenzo², Javier Antoñanzas-Pérez¹, Ana Morelló-Vicente¹, Inés Oteiza-Rius¹, Carolina Arean Cuns³, Jillian Wells^{4

5}, Francisco Javier García-Martínez⁶

Affiliations

¹ Dermatology Department, Clínica Universidad de Navarra, Pamplona, Spain.
² Medical Oncology Department, Clínica Universidad de Navarra, Madrid, Spain.
³ Pathology Department, Clínica Universidad de Navarra, Madrid, Spain.
⁴ Dermatology Department, Westmead Hospital, Sydney, NSW, Australia.
⁵ Faculty of Medicine, Sydney University, Sydney, NSW, Australia.
⁶ Dermatology Department, Clínica Universidad de Navarra, Madrid, Spain.

PMID: 37427732
DOI: 10.1111/ddg.15066_g

No abstract available

Keywords: Capecitabin; Chemotherapie; Fluoropyrimidine; Mycosis fungoides; Sonographie; capecitabine; chemotherapy; fluoropyrimidines; mycosis fungoides; sonography.

Publication types

Letter